Ascendis Pharma Growth Disorders A/s

This study continues testing a weekly injection called TransCon CNP in children and teenagers with achondroplasia, a genetic condition that affects bone growth. It's for participants who have already completed an earlier trial with the same medication. The main goals are to check…

This study is testing whether two weekly injections can safely help children with achondroplasia grow taller. It involves 22 children aged 2-11 years who will receive the treatment for 3 years. Researchers want to see if combining these two medications works better than one alone…